AOWM
IMMU

Alpha Omega Wealth Management’s Immunomedics Inc IMMU Stock Holding History

Alpha Omega Wealth Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-344
Closed -$5K – 606
2019
Q2 		$5K Hold
344
– – ﹤0.01% 509
2019
Q1 		$7K Buy
+344
New +$5.54K ﹤0.01% 461

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Alpha Omega Wealth Management's IMMU Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Immunomedics Inc (IMMU) in Q3 2019, closing a stake of 344 shares — an estimated $5K sold.

Alpha Omega Wealth Management first reported a position in IMMU in Q1 2019 and held it in 2 quarters. The position peaked at $7K in Q1 2019. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

  • Alpha Omega Wealth Management reported no remaining Immunomedics Inc position as of Q3 2019 after selling out during the quarter.
  • Alpha Omega Wealth Management sold 344 Immunomedics Inc shares in Q3 2019, an estimated $5K.
  • Alpha Omega Wealth Management first reported a position in Immunomedics Inc in Q1 2019 and held it in 2 quarters.
  • Alpha Omega Wealth Management's Immunomedics Inc position peaked at $7K in Q1 2019.
  • 208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.